Developer docs
API playgroundTry for free, no card

Search company profiles

SA Pathology

Full company profile

uuid002gsos

Namestring
SA Pathology
Legal namestring
SA Pathology
Company typeenum
Private
Founded yearint
1938
Descriptiontext

SA Pathology is South Australia's state-wide public pathology service, operating as a not-for-profit government-owned entity within Statewide Clinical Support Services (SCSS) under SA Health. Founded in 1938 as the Institute of Medical and Veterinary Science (IMVS) and renamed in 2008 following amalgamation with Women's and Children's Hospital Pathology and Southern Pathology, the organization holds approximately 75% of South Australia's pathology market share and touches 50% of the state's population annually. It delivers comprehensive diagnostic testing across anatomical pathology, chemical pathology, genetics and molecular pathology, haematology, immunology, and microbiology and infectious diseases, supported by specialized reference laboratories including a WHO-recognized Supranational TB Reference Laboratory, the Australian Salmonella Reference Centre, the National Mycology Reference Centre, and a Leukaemia Unit.

The service operates through a distribution network of over 100 collection centres spanning metropolitan Adelaide and regional South Australia, supplemented by hospital-based laboratories at Royal Adelaide, Flinders Medical Centre, Lyell McEwin, Women's and Children's, Queen Elizabeth, and Modbury hospitals, plus home-based domiciliary visits for mobility-impaired patients and online booking at 14+ centres. Results delivery is handled via the iPath web portal and EDI integrations with clinical software (Medical Director, Best Practice, Genie, Zedmed). Technology differentiators include NATA/NPAAC ISO 15189-accredited genomic sequencing (clinical exome, whole genome, somatic panels), cytogenomics, and a catalogue of 4,500+ diagnostic tests. Patient experience innovations include Smileyscope VR and BUZZY pain-distraction devices at paediatric collection centres, achieving 98% patient approval ratings.

The business model is anchored in Medicare bulk-billing (no out-of-pocket cost for eligible patients), with supplementary revenue from fee-for-service non-Medicare tests, private health insurance billing, interstate hospital referrals (at 125% of MBS fee), commercial drug and alcohol workplace testing, food and environmental laboratory services, and research/clinical trial fee-for-service testing. Research output is substantial, with 80+ active grants and contracts through the Centre for Cancer Biology (alliance with University of South Australia) and Hanson Institute (partnership with Royal Adelaide Hospital). Customer segments span the SA public health system (GPs, hospitals, Local Health Networks), individual patients, pregnant women and families (via SAMSAS, NIPT, newborn screening, reproductive carrier testing), specialist practitioners, commercial businesses (food safety, aged care), and research institutions.

Short descriptiontext

SA Pathology is South Australia's state-wide public pathology service, providing comprehensive diagnostic testing across 100+ collection centres and serving 75% of the state's pathology requirements with bulk-billed Medicare services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersAdelaide, Australia
HQ citystring
Adelaide
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostic pathology testing, medical laboratory services, genomic sequencing testing, newborn screening program, food and environmental testing
Industry4 codes
PRIMARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAAALAI
Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays)
SECONDARYHLAFAMAA
Anatomic Pathology (Histopathology & Cytopathology)
SECONDARYHLAGAEAC
Anatomic Pathology & Histopathology (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code2 codes
  • Medical Laboratories621511
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Testing Laboratories8734
Product category
Diagnostic Pathology Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model7 records
1Medicare Bulk-Billing
TypeSubscription Recurring
Description

SA Pathology bulk-bills Medicare for all items covered by Medicare, meaning most patients incur no out-of-pocket expenses. This is the primary revenue stream as a not-for-profit public healthcare organisation.

sapathology.sa.gov.au
2Fee-for-Service Testing
TypeTransaction Fee
Description

Revenue from tests or services not funded by the Commonwealth which do not have a Medicare item number. Patients receive invoices for non-Medicare listed tests and must complete an Agreement to Pay form.

sapathology.sa.gov.au
3Private Health Insurance Billing
TypeTransaction Fee
Description

Private inpatients and day stay patients are billed through private health insurers where possible, or invoiced directly for presentation to Medicare and private health insurer.

sapathology.sa.gov.au
4Commercial Drug and Alcohol Testing
TypeProfessional Services
Description

Workplace drug and alcohol testing services for commercial organisations including confirmation testing, with collection services at accredited collection centres.

sapathology.sa.gov.au
5Food and Environmental Testing Services
TypeProfessional Services
Description

Microbiological and chemical testing services for commercial industries, local businesses, and government agencies for food safety, water quality, and environmental compliance.

sapathology.sa.gov.au
6Research and Clinical Trial Testing
TypeProfessional Services
Description

Fee-for-service analysis of samples for clinical trials, research projects, and commercial purposes at competitive rates.

sapathology.sa.gov.au
7Interstate Hospital Referrals
TypeTransaction Fee
Description

Interstate hospitals and approved pathology providers referring tests to SA Pathology are invoiced at 125% of MBS fee, with non-MBS tests billed at 125% of SA Pathology Pathology Collection Guide fees.

sapathology.sa.gov.au
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components7 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain, Others
Pricing details4 tiers
1Standard Medicare-Bulk-Billed Tests
ModelSubscriptionBilling cadencePay-as-you-go
Notes

All Medicare-listed pathology tests bulk-billed with no out-of-pocket expenses for eligible patients with Medicare card. Patient signature required on pathology request form assignment box.

sapathology.sa.gov.au
2Non-Medicare Tests
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Tests without Medicare item numbers require patient Agreement to Pay form and result in invoices sent to patients.

sapathology.sa.gov.au
3Research and Commercial Testing
ModelOtherBilling cadenceMulti-year contract
Notes

Competitive rates for clinical trials and research projects. Quote requested via form submission. Interstate hospital referrals billed at 125% of MBS fee.

sapathology.sa.gov.au
4Reproductive Carrier Testing
ModelSubscriptionBilling cadencePay-as-you-go
Notes

From 1 November 2023, reproductive carrier testing for CF, SMA, and FRAX is bulk-billed (no out-of-pocket cost) for Medicare-eligible individuals who are pregnant or planning pregnancy. Follow-up partner testing also bulk-billed if initial test identifies carrier status.

sapathology.sa.gov.au
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

SA Pathology is South Australia's state-wide public pathology provider delivering comprehensive diagnostic testing across anatomical pathology, chemical pathology, genetics and molecular pathology, haematology, immunology, microbiology, and infectious diseases. Services are accessed through a network of 80+ collection centres, hospital laboratories, and home-based domiciliary visits, with results delivered electronically via the iPath portal and EDI software. Specialised offerings include newborn screening, maternal serum screening, NIPT, reproductive carrier testing, reference laboratory services, commercial drug/alcohol testing, and food/environmental testing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 50% of South Australia's population served annually
+5 more records
Product overview1 text field

SA Pathology is South Australia's state-wide public pathology service operating as a unified platform with multiple integrated components. The core service provides diagnostic pathology testing through a network of over 100 collection centres across metropolitan and regional South Australia, supported by specialist laboratories including Genetics and Molecular Pathology (GMP), the Mycobacterium Reference Laboratory, Australian Salmonella Reference Centre, National Mycology Reference Centre, and Leukaemia Unit. Patient-facing offerings include SAMSAS (maternal serum screening), the Newborn Bloodspot Screening Program, Non-Invasive Pregnancy Testing (NIPT/Nest), Reproductive Carrier Testing, and Respiratory Testing. Results are delivered through the iPath web portal and EDI software integration with clinical systems. Commercial services encompass Drug and Alcohol Testing and the Food and Environmental Laboratory. Supporting patient experience tools include Smileyscope VR and BUZZY for paediatric needle procedures.

Product and service21 records
1Genetics and Molecular Pathology (GMP)
CategoryGenetic and Molecular Diagnostic Testing
Description

NATA/NPAAC (ISO 15189) accredited genetic testing laboratory offering clinical exome and whole genome sequencing for inherited conditions, and somatic sequencing for solid tumours and haematological malignancies using targeted next-generation sequencing panels. Serves clinicians across South Australia and interstate referrals.

2Newborn Bloodspot Screening Program
CategoryPopulation Health Screening
Description

State-wide screening for over 30 metabolic, endocrine, haematological, and genetic disorders using a blood sample collected within 48-72 hours of birth. Provided to all newborns in South Australia.

3SAMSAS (Maternal Serum Antenatal Screening)
CategoryPrenatal Screening
Description

Accredited laboratory service providing comprehensive risk assessment for Down syndrome (trisomy 21), other autosomal aneuploidies, and open neural tube defects during pregnancy.

4Non-Invasive Pregnancy Testing (NIPT/Nest)
CategoryPrenatal Screening
Description

First-trimester prenatal screening using whole genome sequencing of cell-free DNA to determine chance of chromosome conditions such as Trisomy 21, 13, and 18, performed from 10 weeks gestation.

5Reproductive Carrier Testing
CategoryGenetic Carrier Screening
Description

Genetic testing for Cystic Fibrosis (CF), Spinal Muscular Atrophy (SMA), and Fragile X Syndrome (FRAX) carrier status, bulk-billed for eligible Medicare patients planning or currently pregnant. From 1 November 2023, bulk-billing applies for initial and follow-up partner testing.

6Omega-3 Status Testing
CategoryPrenatal Risk Assessment
Description

Blood testing for omega-3 status in pregnant women to assess preterm birth risk, offered in collaboration with SAHMRI as a world-first free program based on 20 years of research. Has tested around 37,000 pregnant women since 2021.

7Self-Collect Cervical Screening
CategoryCancer Screening
Description

HPV self-collection option for cervical screening, available to women aged 25 years or older who need HPV testing and have a cervix (excluding pregnant women), with GP referral.

8Respiratory PCR Testing
CategoryInfectious Disease Diagnostics
Description

PCR testing for respiratory pathogens including influenza A & B, RSV, metapneumovirus, parainfluenza, adenovirus, rhinovirus, Mycoplasma, Bordetella pertussis, and COVID-19, with self-collect and collection centre options.

9Mycobacterium Reference Laboratory
CategoryReference Laboratory Services
Description

WHO-recognised Supranational TB Reference Laboratory providing diagnostic and reference services for tuberculosis and non-tuberculosis mycobacteria, including whole genome sequencing for cluster investigations and AMR detection. Provides education and technical support to National Reference Laboratories in Kiribati, Solomon Islands, Vietnam, and Indonesia.

10Australian Salmonella Reference Centre
CategoryReference Laboratory Services
Description

National reference centre providing serotyping, biotyping, and molecular subtyping services for Salmonella identification in human, animal, food, and environmental isolates for public health surveillance. Runs the ANZERN National Proficiency Testing program in Salmonella serotyping.

11National Mycology Reference Centre
CategoryReference Laboratory Services
Description

National referral centre providing mycology testing services including fungal microscopy, culture, susceptibility testing, dermatophyte PCR, and expert advice on fungal diagnostics. Delivers the Mycology Masterclass course nationally.

12Leukaemia Unit
CategoryReference Laboratory Services
Description

National referral laboratory for characterisation of rare gene fusion transcripts in CML patients with atypical molecular profiles, and one of few Australian laboratories performing drug resistance mutation testing.

13National Referral Laboratory for Rare Inherited Metabolic Conditions
CategoryReference Laboratory Services
Description

Centre of excellence for diagnostic testing of lysosomal storage disorders, peroxisomal disorders, and other rare inherited metabolic conditions, providing biochemical screens, enzyme analyses, and molecular testing through the Genomics Unit.

14Drug and Alcohol Testing
CategoryCommercial Testing Services
Description

Workplace drug and alcohol testing service with collection services at accredited collection centres, detecting controlled and illegal substances per Australian toxicology standards, with local confirmation testing in Adelaide. NATA certified.

15Food and Environmental Laboratory
CategoryCommercial Testing Services
Description

Microbiological and chemical testing for foods, beverages, waters, cosmetics, and pharmaceutical products for harmful bacteria including Salmonella, Listeria, Campylobacter, E. coli, and Legionella programs for water systems. NATA accredited.

16Antibiotic Susceptibility Testing
CategoryMicrobiology Diagnostics
Description

Antimicrobial susceptibility testing following EUCAST guidelines, providing susceptible and resistant results with dosage tables for standard, high dose, and uncomplicated UTI dosing recommendations.

17iPath Results Platform
CategoryResults Delivery Platform
Description

Web-based pathology result delivery solution providing clinicians access to pathology results with enhanced search functionality for finding patient results across the public hospital system.

18Collection Centre Network Service
CategoryPatient Service Delivery
Description

State-wide network of over 80 collection centres across metropolitan Adelaide and regional South Australia, offering general pathology plus specialised paediatric, STI screening, ECG, urine drug screening, and venesections services.

19Domiciliary Visit Service
CategoryPatient Service Delivery
Description

Home-based blood collection service for patients unable to attend collection centres, including recently discharged hospital patients, mobility-impaired individuals, and residential aged care facility residents, with doctor referral.

20Smileyscope VR Patient Experience Service
CategoryPatient Experience Service
Description

Virtual reality headset service offering relaxing VR and meditation programs with evidence-based music therapy to distract paediatric patients from needle procedures, available at select paediatric collection centres.

21BUZZY Pain Distraction Service
CategoryPatient Experience Service
Description

Pain management service using nerve stimulation and mental distraction with ice-pack wings and vibrations based on the gate control theory of pain, awarded 98% approval rating from SA Pathology patients.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on world-first free omega-3 testing program for pregnant women to prevent preterm birth. Based on 20 years of research, the program will introduce free omega-3 blood tests from June 1 for pregnant women with singleton pregnancies before 20 weeks' gestation. SAHMRI researchers found direct link between low omega-3 levels and preterm delivery risk.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alliance to operate the Centre for Cancer Biology, an internationally recognised cancer research centre hosting over 20 group leaders and teams. Research teams actively form alliances with pharmaceutical companies to foster knowledge and advance new treatments.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership through the Hanson Institute, established in 1991 as an internationally recognised research partnership between SA Pathology and the Royal Adelaide Hospital, working in close collaboration with other South Australian medical research organisations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership providing specialist pathology services including paediatric pathology, perinatal pathology, and women's health diagnostics. SA Pathology operates collection centre and laboratories at Women's and Children's Hospital site.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pathology services partnership providing diagnostic testing to Royal Adelaide Hospital and associated facilities within the Central Adelaide Local Health Network.

6Southern Adelaide Local Health Network (SALHN)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pathology services partnership providing diagnostic testing to Flinders Medical Centre, Flinders Private Hospital, and associated SALHN facilities.

sapathology.sa.gov.au
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pathology services partnership providing diagnostic testing to Lyell McEwin Health Service and associated NALHN facilities.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnerships with regional hospitals including Barmera, Berri, Ceduna, Clare, Port Augusta, Port Lincoln, Port Pirie, Murray Bridge, Wallaroo, Whyalla, Mount Gambier, and Victor Harbor for pathology collection and testing services.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Historical partnership through Institute of Medical and Veterinary Science (IMVS) with strong historical links to University of Adelaide for pathology training and medical research.

10Statewide Clinical Support Services (SCSS)
Strategic tierCoreTypeOthers
Description

SA Pathology is a member of Statewide Clinical Support Services (SCSS), a public healthcare organisation serving health consumers and providing specialist clinical services to the health system in South Australia.

sapathology.sa.gov.au
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Primary government health partner for state-wide pathology services, food and environmental testing, and public health response during disease outbreaks and food/environmental threats.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

ASX-listed national pathology operator providing comprehensive diagnostic testing to GPs, specialists, and hospitals across Australia. Highly comparable to SA Pathology in test menu breadth (anatomical, chemical, genetics, microbiology) and customer base, though privately listed and commercially operated.

TypeBroad incumbent
Description

US-based nonprofit clinical and reference laboratory owned by University of Utah, specialising in esoteric and complex diagnostic testing. Highly comparable to SA Pathology's specialised reference lab functions (TB, Salmonella, mycology, leukaemia) and academic/research integration model.

TypeDirect peer
Description

Australia's largest private pathology operator with a national network of laboratories and collection centres. Directly comparable business model to SA Pathology (diagnostic testing across all pathology disciplines, hospital and GP referrals, NATA-accredited), but operates commercially across multiple states rather than as a single-state public monopoly.

TypeDirect peer
Description

Western Australia's state public pathology service, operating laboratories and collection centres across metropolitan and regional WA. Closely comparable to SA Pathology as a state-government public pathology operator offering comprehensive diagnostic testing, reference lab functions, and forensic services.

TypeRegional player
Description

Victorian public genetics and genomics service (part of Murdoch Children's Research Institute) offering reproductive carrier screening, NIPT, and clinical genetics. Comparable to SA Pathology's genetics and molecular pathology portfolio (NIPT, reproductive carrier testing, newborn screening) but focused on genomics rather than full-service pathology.

TypeBroad incumbent
Description

One of the world's largest clinical laboratory networks, providing routine and advanced diagnostic testing with significant reference laboratory capability. Comparable to SA Pathology in broad test menu and clinical trial support services, though global in scale and US-listed.

TypeBroad incumbent
Description

Global clinical laboratory giant offering routine and esoteric diagnostic testing across North America and internationally. Comparable to SA Pathology's full-service clinical diagnostics and reference laboratory functions (specialised genetics, microbiology, oncology), though operating at vastly greater scale and as a commercial entity.

TypeDirect peer
Description

State-wide public pathology service for New South Wales operating under NSW Health, providing diagnostic testing across metropolitan and regional NSW. Functionally equivalent peer to SA Pathology in mandate, governance structure, and service scope (hospital labs, collection centres, reference laboratories, public-health response).

9Genomics England
TypeOthers
Description

UK Government-owned genomics initiative delivering whole genome sequencing at population scale for the NHS. Comparable to SA Pathology's genomics and newborn screening programs (population-scale screening, WGS infrastructure, public-health mandate) but operates at national scope and as a dedicated genomics entity rather than full-service pathology.

TypeDirect peer
Description

Major ASX-listed Australian pathology operator (formerly Primary Health Care) running a national network of laboratories and collection centres. Directly comparable to SA Pathology in offering routine and specialised pathology, with a similar broad test menu and hospital/GP customer base, but with commercial reach across states.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SA Pathology

Diagnostic Pathology Servicessapathology.sa.gov.au

SA Pathology is South Australia's state-wide public pathology service, providing comprehensive diagnostic testing across 100+ collection centres and serving 75% of the state's pathology requirements with bulk-billed Medicare services.

What SA Pathology does

SA Pathology is South Australia's state-wide public pathology service, operating as a not-for-profit government-owned entity within Statewide Clinical Support Services (SCSS) under SA Health. Founded in 1938 as the Institute of Medical and Veterinary Science (IMVS) and renamed in 2008 following amalgamation with Women's and Children's Hospital Pathology and Southern Pathology, the organization holds approximately 75% of South Australia's pathology market share and touches 50% of the state's population annually. It delivers comprehensive diagnostic testing across anatomical pathology, chemical pathology, genetics and molecular pathology, haematology, immunology, and microbiology and infectious diseases, supported by specialized reference laboratories including a WHO-recognized Supranational TB Reference Laboratory, the Australian Salmonella Reference Centre, the National Mycology Reference Centre, and a Leukaemia Unit.

The service operates through a distribution network of over 100 collection centres spanning metropolitan Adelaide and regional South Australia, supplemented by hospital-based laboratories at Royal Adelaide, Flinders Medical Centre, Lyell McEwin, Women's and Children's, Queen Elizabeth, and Modbury hospitals, plus home-based domiciliary visits for mobility-impaired patients and online booking at 14+ centres. Results delivery is handled via the iPath web portal and EDI integrations with clinical software (Medical Director, Best Practice, Genie, Zedmed). Technology differentiators include NATA/NPAAC ISO 15189-accredited genomic sequencing (clinical exome, whole genome, somatic panels), cytogenomics, and a catalogue of 4,500+ diagnostic tests. Patient experience innovations include Smileyscope VR and BUZZY pain-distraction devices at paediatric collection centres, achieving 98% patient approval ratings.

The business model is anchored in Medicare bulk-billing (no out-of-pocket cost for eligible patients), with supplementary revenue from fee-for-service non-Medicare tests, private health insurance billing, interstate hospital referrals (at 125% of MBS fee), commercial drug and alcohol workplace testing, food and environmental laboratory services, and research/clinical trial fee-for-service testing. Research output is substantial, with 80+ active grants and contracts through the Centre for Cancer Biology (alliance with University of South Australia) and Hanson Institute (partnership with Royal Adelaide Hospital). Customer segments span the SA public health system (GPs, hospitals, Local Health Networks), individual patients, pregnant women and families (via SAMSAS, NIPT, newborn screening, reproductive carrier testing), specialist practitioners, commercial businesses (food safety, aged care), and research institutions.

SA Pathology firmographics

Firmographics
Name
SA Pathology
Legal name
SA Pathology
Website
https://sapathology.sa.gov.au
Company type
Private
Founded year
1938
Operating status
Operating
Headcount range
501–1,000 employees
Short description
SA Pathology is South Australia's state-wide public pathology service, providing comprehensive diagnostic testing across 100+ collection centres and serving 75% of the state's pathology requirements with bulk-billed Medicare services.
Ownership category
akta.pro rank

SA Pathology industry classification

Industry
Product category
Diagnostic Pathology Services
NAICS
Medical Laboratories (621511), Scientific Research and Development Services (5417)
SIC
Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAAALAI
Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays)
SECONDARYHLAFAMAA
Anatomic Pathology (Histopathology & Cytopathology)
SECONDARYHLAGAEAC
Anatomic Pathology & Histopathology (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Diagnostic pathology testing
  • Medical laboratory services
  • Genomic sequencing testing
  • Newborn screening program
  • Food and environmental testing

Where SA Pathology is headquartered

Location

Headquarters

HQ city
Adelaide
HQ country
Australia
HQ region
Oceania

Offices10 records

Markets served

SA Pathology business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain, Others

Revenue model

  1. Medicare Bulk-Billing: SA Pathology bulk-bills Medicare for all items covered by Medicare, meaning most patients incur no out-of-pocket expenses. This is the primary revenue stream as a not-for-profit public healthcare organisation.
  2. Fee-for-Service Testing: Revenue from tests or services not funded by the Commonwealth which do not have a Medicare item number. Patients receive invoices for non-Medicare listed tests and must complete an Agreement to Pay form.
  3. Private Health Insurance Billing: Private inpatients and day stay patients are billed through private health insurers where possible, or invoiced directly for presentation to Medicare and private health insurer.
  4. Commercial Drug and Alcohol Testing: Workplace drug and alcohol testing services for commercial organisations including confirmation testing, with collection services at accredited collection centres.
  5. Food and Environmental Testing Services: Microbiological and chemical testing services for commercial industries, local businesses, and government agencies for food safety, water quality, and environmental compliance.
  6. Research and Clinical Trial Testing: Fee-for-service analysis of samples for clinical trials, research projects, and commercial purposes at competitive rates.
  7. Interstate Hospital Referrals: Interstate hospitals and approved pathology providers referring tests to SA Pathology are invoiced at 125% of MBS fee, with non-MBS tests billed at 125% of SA Pathology Pathology Collection Guide fees.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goStandard Medicare-Bulk-Billed Tests
One time/ perpetual licensePay-as-you-goNon-Medicare Tests
OtherMulti-year contractResearch and Commercial Testing
SubscriptionPay-as-you-goReproductive Carrier Testing

Go-to-market motion3 records

Distribution channels6 records

Marketing channels6 records

SA Pathology product offering

Product offering

Core offering

SA Pathology is South Australia's state-wide public pathology provider delivering comprehensive diagnostic testing across anatomical pathology, chemical pathology, genetics and molecular pathology, haematology, immunology, microbiology, and infectious diseases. Services are accessed through a network of 80+ collection centres, hospital laboratories, and home-based domiciliary visits, with results delivered electronically via the iPath portal and EDI software. Specialised offerings include newborn screening, maternal serum screening, NIPT, reproductive carrier testing, reference laboratory services, commercial drug/alcohol testing, and food/environmental testing.

Product overview

SA Pathology is South Australia's state-wide public pathology service operating as a unified platform with multiple integrated components. The core service provides diagnostic pathology testing through a network of over 100 collection centres across metropolitan and regional South Australia, supported by specialist laboratories including Genetics and Molecular Pathology (GMP), the Mycobacterium Reference Laboratory, Australian Salmonella Reference Centre, National Mycology Reference Centre, and Leukaemia Unit. Patient-facing offerings include SAMSAS (maternal serum screening), the Newborn Bloodspot Screening Program, Non-Invasive Pregnancy Testing (NIPT/Nest), Reproductive Carrier Testing, and Respiratory Testing. Results are delivered through the iPath web portal and EDI software integration with clinical systems. Commercial services encompass Drug and Alcohol Testing and the Food and Environmental Laboratory. Supporting patient experience tools include Smileyscope VR and BUZZY for paediatric needle procedures.

Differentiator

Problem solved

Functional benefit

Products and services

  • Genetics and Molecular Pathology (GMP) NATA/NPAAC (ISO 15189) accredited genetic testing laboratory offering clinical exome and whole genome sequencing for inherited conditions, and somatic sequencing for solid tumours and haematological malignancies using targeted next-generation sequencing panels. Serves clinicians across South Australia and interstate referrals.
  • Newborn Bloodspot Screening Program State-wide screening for over 30 metabolic, endocrine, haematological, and genetic disorders using a blood sample collected within 48-72 hours of birth. Provided to all newborns in South Australia.
  • SAMSAS (Maternal Serum Antenatal Screening) Accredited laboratory service providing comprehensive risk assessment for Down syndrome (trisomy 21), other autosomal aneuploidies, and open neural tube defects during pregnancy.
  • Non-Invasive Pregnancy Testing (NIPT/Nest) First-trimester prenatal screening using whole genome sequencing of cell-free DNA to determine chance of chromosome conditions such as Trisomy 21, 13, and 18, performed from 10 weeks gestation.
  • Reproductive Carrier Testing Genetic testing for Cystic Fibrosis (CF), Spinal Muscular Atrophy (SMA), and Fragile X Syndrome (FRAX) carrier status, bulk-billed for eligible Medicare patients planning or currently pregnant. From 1 November 2023, bulk-billing applies for initial and follow-up partner testing.
  • Omega-3 Status Testing Blood testing for omega-3 status in pregnant women to assess preterm birth risk, offered in collaboration with SAHMRI as a world-first free program based on 20 years of research. Has tested around 37,000 pregnant women since 2021.
  • Self-Collect Cervical Screening HPV self-collection option for cervical screening, available to women aged 25 years or older who need HPV testing and have a cervix (excluding pregnant women), with GP referral.
  • Respiratory PCR Testing PCR testing for respiratory pathogens including influenza A & B, RSV, metapneumovirus, parainfluenza, adenovirus, rhinovirus, Mycoplasma, Bordetella pertussis, and COVID-19, with self-collect and collection centre options.
  • Mycobacterium Reference Laboratory WHO-recognised Supranational TB Reference Laboratory providing diagnostic and reference services for tuberculosis and non-tuberculosis mycobacteria, including whole genome sequencing for cluster investigations and AMR detection. Provides education and technical support to National Reference Laboratories in Kiribati, Solomon Islands, Vietnam, and Indonesia.
  • Australian Salmonella Reference Centre National reference centre providing serotyping, biotyping, and molecular subtyping services for Salmonella identification in human, animal, food, and environmental isolates for public health surveillance. Runs the ANZERN National Proficiency Testing program in Salmonella serotyping.
  • National Mycology Reference Centre National referral centre providing mycology testing services including fungal microscopy, culture, susceptibility testing, dermatophyte PCR, and expert advice on fungal diagnostics. Delivers the Mycology Masterclass course nationally.
  • Leukaemia Unit National referral laboratory for characterisation of rare gene fusion transcripts in CML patients with atypical molecular profiles, and one of few Australian laboratories performing drug resistance mutation testing.
  • National Referral Laboratory for Rare Inherited Metabolic Conditions Centre of excellence for diagnostic testing of lysosomal storage disorders, peroxisomal disorders, and other rare inherited metabolic conditions, providing biochemical screens, enzyme analyses, and molecular testing through the Genomics Unit.
  • Drug and Alcohol Testing Workplace drug and alcohol testing service with collection services at accredited collection centres, detecting controlled and illegal substances per Australian toxicology standards, with local confirmation testing in Adelaide. NATA certified.
  • Food and Environmental Laboratory Microbiological and chemical testing for foods, beverages, waters, cosmetics, and pharmaceutical products for harmful bacteria including Salmonella, Listeria, Campylobacter, E. coli, and Legionella programs for water systems. NATA accredited.
  • Antibiotic Susceptibility Testing Antimicrobial susceptibility testing following EUCAST guidelines, providing susceptible and resistant results with dosage tables for standard, high dose, and uncomplicated UTI dosing recommendations.
  • iPath Results Platform Web-based pathology result delivery solution providing clinicians access to pathology results with enhanced search functionality for finding patient results across the public hospital system.
  • Collection Centre Network Service State-wide network of over 80 collection centres across metropolitan Adelaide and regional South Australia, offering general pathology plus specialised paediatric, STI screening, ECG, urine drug screening, and venesections services.
  • Domiciliary Visit Service Home-based blood collection service for patients unable to attend collection centres, including recently discharged hospital patients, mobility-impaired individuals, and residential aged care facility residents, with doctor referral.
  • Smileyscope VR Patient Experience Service Virtual reality headset service offering relaxing VR and meditation programs with evidence-based music therapy to distract paediatric patients from needle procedures, available at select paediatric collection centres.
  • BUZZY Pain Distraction Service Pain management service using nerve stimulation and mental distraction with ice-pack wings and vibrations based on the gate control theory of pain, awarded 98% approval rating from SA Pathology patients.

Quantifiable outcome

  • 50% of South Australia's population served annually
  • +5 more outcomes

Companies that use SA Pathology

Customer profile

Named customers10 records

Segments6 records

Ideal customer profiles5 records

SA Pathology technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature11 records

SA Pathology partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • South Australian Health and Medical Research Institute (SAHMRI)coreStrategic or Co-development PartnerCollaboration on world-first free omega-3 testing program for pregnant women to prevent preterm birth. Based on 20 years of research, the program will introduce free omega-3 blood tests from June 1 for pregnant women with singleton pregnancies before 20 weeks' gestation. SAHMRI researchers found direct link between low omega-3 levels and preterm delivery risk.
  • University of South Australia (UniSA)coreStrategic or Co-development PartnerAlliance to operate the Centre for Cancer Biology, an internationally recognised cancer research centre hosting over 20 group leaders and teams. Research teams actively form alliances with pharmaceutical companies to foster knowledge and advance new treatments.
  • Royal Adelaide HospitalcoreStrategic or Co-development PartnerResearch partnership through the Hanson Institute, established in 1991 as an internationally recognised research partnership between SA Pathology and the Royal Adelaide Hospital, working in close collaboration with other South Australian medical research organisations.
  • Women's and Children's Health NetworkcoreStrategic or Co-development PartnerPartnership providing specialist pathology services including paediatric pathology, perinatal pathology, and women's health diagnostics. SA Pathology operates collection centre and laboratories at Women's and Children's Hospital site.
  • Central Adelaide Local Health Network (CALHN)coreStrategic or Co-development PartnerPathology services partnership providing diagnostic testing to Royal Adelaide Hospital and associated facilities within the Central Adelaide Local Health Network.
  • Southern Adelaide Local Health Network (SALHN)coreStrategic or Co-development PartnerPathology services partnership providing diagnostic testing to Flinders Medical Centre, Flinders Private Hospital, and associated SALHN facilities.
  • Northern Adelaide Local Health Network (NALHN)coreStrategic or Co-development PartnerPathology services partnership providing diagnostic testing to Lyell McEwin Health Service and associated NALHN facilities.
  • Regional Local Health NetworkscoreChannel Partner/ Reseller/ DistributorPartnerships with regional hospitals including Barmera, Berri, Ceduna, Clare, Port Augusta, Port Lincoln, Port Pirie, Murray Bridge, Wallaroo, Whyalla, Mount Gambier, and Victor Harbor for pathology collection and testing services.
  • University of AdelaideminorStrategic or Co-development PartnerHistorical partnership through Institute of Medical and Veterinary Science (IMVS) with strong historical links to University of Adelaide for pathology training and medical research.
  • Statewide Clinical Support Services (SCSS)coreOthersSA Pathology is a member of Statewide Clinical Support Services (SCSS), a public healthcare organisation serving health consumers and providing specialist clinical services to the health system in South Australia.
  • SA HealthcoreStrategic or Co-development PartnerPrimary government health partner for state-wide pathology services, food and environmental testing, and public health response during disease outbreaks and food/environmental threats.

Scale indicators8 records

Recent moves8 records

Expansion highlights5 records

SA Pathology competitors and assessment

Company assessment

Direct peers

  • Australian Clinical Labs: ASX-listed national pathology operator providing comprehensive diagnostic testing to GPs, specialists, and hospitals across Australia. Highly comparable to SA Pathology in test menu breadth (anatomical, chemical, genetics, microbiology) and customer base, though privately listed and commercially operated.
  • Sonic Healthcare: Australia's largest private pathology operator with a national network of laboratories and collection centres. Directly comparable business model to SA Pathology (diagnostic testing across all pathology disciplines, hospital and GP referrals, NATA-accredited), but operates commercially across multiple states rather than as a single-state public monopoly.
  • PathWest: Western Australia's state public pathology service, operating laboratories and collection centres across metropolitan and regional WA. Closely comparable to SA Pathology as a state-government public pathology operator offering comprehensive diagnostic testing, reference lab functions, and forensic services.
  • NSW Health Pathology: State-wide public pathology service for New South Wales operating under NSW Health, providing diagnostic testing across metropolitan and regional NSW. Functionally equivalent peer to SA Pathology in mandate, governance structure, and service scope (hospital labs, collection centres, reference laboratories, public-health response).
  • Healius: Major ASX-listed Australian pathology operator (formerly Primary Health Care) running a national network of laboratories and collection centres. Directly comparable to SA Pathology in offering routine and specialised pathology, with a similar broad test menu and hospital/GP customer base, but with commercial reach across states.

Broad incumbents

  • ARUP Laboratories: US-based nonprofit clinical and reference laboratory owned by University of Utah, specialising in esoteric and complex diagnostic testing. Highly comparable to SA Pathology's specialised reference lab functions (TB, Salmonella, mycology, leukaemia) and academic/research integration model.
  • Quest Diagnostics: One of the world's largest clinical laboratory networks, providing routine and advanced diagnostic testing with significant reference laboratory capability. Comparable to SA Pathology in broad test menu and clinical trial support services, though global in scale and US-listed.
  • LabCorp: Global clinical laboratory giant offering routine and esoteric diagnostic testing across North America and internationally. Comparable to SA Pathology's full-service clinical diagnostics and reference laboratory functions (specialised genetics, microbiology, oncology), though operating at vastly greater scale and as a commercial entity.

Regional players

  • Victorian Clinical Genetics Services: Victorian public genetics and genomics service (part of Murdoch Children's Research Institute) offering reproductive carrier screening, NIPT, and clinical genetics. Comparable to SA Pathology's genetics and molecular pathology portfolio (NIPT, reproductive carrier testing, newborn screening) but focused on genomics rather than full-service pathology.

Others

  • Genomics England: UK Government-owned genomics initiative delivering whole genome sequencing at population scale for the NHS. Comparable to SA Pathology's genomics and newborn screening programs (population-scale screening, WGS infrastructure, public-health mandate) but operates at national scope and as a dedicated genomics entity rather than full-service pathology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

SA Pathology social profiles

Digital presence

SA Pathology compliance and trust

Trust signal

Compliance6 records

SA Pathology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SA Pathology leadership team

Management profile

Number of profiles

Profiles7 records

SA Pathology subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

SA Pathology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SA Pathology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SA Pathology

What does SA Pathology do?

SA Pathology is South Australia's state-wide public pathology provider delivering comprehensive diagnostic testing across anatomical pathology, chemical pathology, genetics and molecular pathology, haematology, immunology, microbiology, and infectious diseases. Services are accessed through a network of 80+ collection centres, hospital laboratories, and home-based domiciliary visits, with results delivered electronically via the iPath portal and EDI software. Specialised offerings include newborn screening, maternal serum screening, NIPT, reproductive carrier testing, reference laboratory services, commercial drug/alcohol testing, and food/environmental testing.

Is SA Pathology a public or private company?

SA Pathology is a private company. It is classified as state government owned and is currently operating.

When was SA Pathology founded?

SA Pathology was founded in 1938. It employs 501 to 1,000 people.

Where is SA Pathology based?

SA Pathology is headquartered in Adelaide, Australia, in the Oceania region.

How does SA Pathology make money?

Seven revenue lines are on record. Medicare Bulk-Billing is the primary driver. The others are fee-for-Service Testing, private Health Insurance Billing, commercial Drug and Alcohol Testing, food and Environmental Testing Services, research and Clinical Trial Testing and interstate Hospital Referrals.

Who are SA Pathology's main competitors?

Direct peers on record are Australian Clinical Labs, Sonic Healthcare, PathWest, NSW Health Pathology and Healius. Broad incumbents are ARUP Laboratories, Quest Diagnostics and LabCorp. Victorian Clinical Genetics Services is listed as a regional player. Genomics England is listed as an others.

Does SA Pathology have an API?

No public API is recorded for SA Pathology.

What industry is SA Pathology in?

SA Pathology's product category is Diagnostic Pathology Services. Its primary akta.pro industry code is HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays), with a secondary code of HLAAALAI, Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals